Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
23.87
+0.03 (0.13%)
Sep 26, 2024, 4:00 PM EDT - Market closed
Oruka Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Oruka Therapeutics stock have an average target of 41.33, with a low estimate of 40 and a high estimate of 44. The average target predicts an increase of 73.15% from the current stock price of 23.87.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ORKA stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 |
|---|---|
| Strong Buy | 2 |
| Buy | 2 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $44 | Buy | Initiates | $44 | +84.33% | Sep 17, 2024 |
| Leerink Swann | Leerink Swann | Buy Initiates $44 | Buy | Initiates | $44 | +84.33% | Sep 17, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Sep 16, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +67.57% | Sep 13, 2024 |
| Wedbush | Wedbush | Buy Initiates $40 | Buy | Initiates | $40 | +67.57% | Sep 4, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.